Abraaj pulls out from Tunisian pharma company
02 Nov 2013
(MENAFN) Dubai’s Abraaj Group said that it is pulling out from Tunisian pharmaceutical company Opalia Pharma, Arabian Business reported.
The firm said that it has sold its shares to an international pharmaceutical company called Recordati.
The Abraaj Group first invested in Opalia in 2009 in a deal that marked the Group’s first realisation in the Tunisian market.
Since Then, Abraaj’s involvement with the pharmaceutical company aided in doubling sales.